![Jason Fontenot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Fontenot
Geen lopende functies
Profiel
Jason D.
Fontenot served as the Chief Scientific Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2021 to 2024.
Prior to that, he was the Chief Scientific Officer at Immusoft Corp.
from 2018 to 2019.
Before joining Immusoft Corp., he worked as the Head-Exploratory Research at Juno Therapeutics, Inc. from 2016 to 2018.
Mr. Fontenot holds a doctorate degree from the University of Washington.
Eerdere bekende functies van Jason Fontenot
| Bedrijven | Functie | Einde |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 02-01-2024 |
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Hoofd Techniek/Wetenschap/O&O | 01-03-2019 |
| JUNO THERAPEUTICS INC | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
Opleiding van Jason Fontenot
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Health Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
